Publication:
QT prolongation risk with antiemetics during COVID 19 treatment

dc.contributor.authorSANCAR, MESUT
dc.contributor.authorsAksoy, Nilay; Sancar, Mesut
dc.date.accessioned2022-03-11T23:50:37Z
dc.date.accessioned2026-01-11T06:02:03Z
dc.date.available2022-03-11T23:50:37Z
dc.date.issued2021-05
dc.identifier.doi10.1111/ijcp.14041
dc.identifier.eissn1742-1241
dc.identifier.issn1368-5031
dc.identifier.pubmed33887871
dc.identifier.urihttps://hdl.handle.net/11424/223123
dc.identifier.wosWOS:000644132400065
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofINTERNATIONAL JOURNAL OF CLINICAL PRACTICE
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleQT prolongation risk with antiemetics during COVID 19 treatment
dc.typeother
dc.type.subletter
dspace.entity.typePublication
oaire.citation.issue5
oaire.citation.titleINTERNATIONAL JOURNAL OF CLINICAL PRACTICE
oaire.citation.volume75

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
219.04 KB
Format:
Adobe Portable Document Format